These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 20471260)
1. Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity. Fray MJ; Fish PV; Allan GA; Bish G; Clarke N; Eccles R; Harrison AC; Le Net JL; Phillips SC; Regan N; Sobry C; Stobie A; Wakenhut F; Westbrook D; Westbrook SL; Whitlock GA Bioorg Med Chem Lett; 2010 Jun; 20(12):3788-92. PubMed ID: 20471260 [TBL] [Abstract][Full Text] [Related]
2. N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration. Wakenhut F; Allan GA; Fish PV; Fray MJ; Harrison AC; McCoy R; Phillips SC; Ryckmans T; Stobie A; Westbrook D; Westbrook SL; Whitlock GA Bioorg Med Chem Lett; 2009 Sep; 19(17):5078-81. PubMed ID: 19647430 [TBL] [Abstract][Full Text] [Related]
3. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships. Fish PV; Andrews MD; Jonathan Fray M; Stobie A; Wakenhut F; Whitlock GA Bioorg Med Chem Lett; 2009 May; 19(10):2829-34. PubMed ID: 19359175 [TBL] [Abstract][Full Text] [Related]
4. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor. Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359 [TBL] [Abstract][Full Text] [Related]
5. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors. Fray MJ; Bish G; Fish PV; Stobie A; Wakenhut F; Whitlock GA Bioorg Med Chem Lett; 2006 Aug; 16(16):4349-53. PubMed ID: 16750363 [TBL] [Abstract][Full Text] [Related]
7. Targeting serotonin and norepinephrine receptors in stress urinary incontinence. Thor KB Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S38-52. PubMed ID: 15302566 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition. Fish PV; Deur C; Gan X; Greene K; Hoople D; Mackenny M; Para KS; Reeves K; Ryckmans T; Stiff C; Stobie A; Wakenhut F; Whitlock GA Bioorg Med Chem Lett; 2008 Apr; 18(8):2562-6. PubMed ID: 18387300 [TBL] [Abstract][Full Text] [Related]
9. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence. Zinner NR Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors. Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106 [TBL] [Abstract][Full Text] [Related]
11. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI). Alberti C G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172 [TBL] [Abstract][Full Text] [Related]
12. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950 [TBL] [Abstract][Full Text] [Related]
14. 8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors--part II. Bromidge SM; Bertani B; Borriello M; Bozzoli A; Faedo S; Gianotti M; Gordon LJ; Hill M; Zucchelli V; Watson JM; Zonzini L Bioorg Med Chem Lett; 2009 Apr; 19(8):2338-42. PubMed ID: 19286377 [TBL] [Abstract][Full Text] [Related]
15. Duloxetine: a new approach for treating stress urinary incontinence. Moore K Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors. Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression. Cashman JR; Ghirmai S Bioorg Med Chem; 2009 Oct; 17(19):6890-7. PubMed ID: 19740668 [TBL] [Abstract][Full Text] [Related]
18. Role of serotonin and noradrenaline in stress urinary incontinence. Michel MC; Peters SL BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860 [No Abstract] [Full Text] [Related]
19. Duloxetine: a new selective and dual-acting antidepressant. Bauer M; Möller HJ; Schneider E Expert Opin Pharmacother; 2006 Mar; 7(4):421-7. PubMed ID: 16503814 [TBL] [Abstract][Full Text] [Related]
20. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors. Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]